These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 19794309

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F, Pantea L, Sniderman K.
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hepatorenal syndrome: a review.
    Testino G, Ferro C.
    Hepatogastroenterology; 2010 Jul; 57(102-103):1279-84. PubMed ID: 21410072
    [Abstract] [Full Text] [Related]

  • 6. The management of hepatorenal syndrome.
    Carl DE, Sanyal A.
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):207-26. PubMed ID: 19305378
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hepatorenal syndrome.
    Bataller R, Arroyo V, Ginès P, Sort P.
    Forum (Genova); 1998 Jun; 8(1):62-81. PubMed ID: 9565447
    [Abstract] [Full Text] [Related]

  • 9. Hepatorenal syndrome.
    Biswas KD, Jain AK.
    Trop Gastroenterol; 2002 Jun; 23(3):113-6. PubMed ID: 12693150
    [Abstract] [Full Text] [Related]

  • 10. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems.
    Guevara M, Ginès P, Bandi JC, Gilabert R, Sort P, Jiménez W, Garcia-Pagan JC, Bosch J, Arroyo V, Rodés J.
    Hepatology; 1998 Aug; 28(2):416-22. PubMed ID: 9696006
    [Abstract] [Full Text] [Related]

  • 11. Treatment of hepatorenal syndrome.
    Kiser TH, Maclaren R, Fish DN.
    Pharmacotherapy; 2009 Oct; 29(10):1196-211. PubMed ID: 19792993
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diagnosis and treatment of hepatorenal syndrome.
    Ginès P.
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):945-57. PubMed ID: 11139348
    [Abstract] [Full Text] [Related]

  • 15. [Hepatorenal syndrome].
    Lautrette A, Liotier J, Deteix P, Souweine B.
    Nephrol Ther; 2009 Apr; 5(2):150-6. PubMed ID: 18514053
    [Abstract] [Full Text] [Related]

  • 16. Therapy insight: Management of hepatorenal syndrome.
    Cárdenas A, Ginès P.
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):338-48. PubMed ID: 16741553
    [Abstract] [Full Text] [Related]

  • 17. Review article: prognosis of hepatorenal syndrome--has it changed with current practice?
    Angeli P.
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():44-6; discussion 47-8. PubMed ID: 15335400
    [Abstract] [Full Text] [Related]

  • 18. Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome.
    Senzolo M, Cholongitas E, Tibballs J, Burroughs A, Patch D.
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1143-50. PubMed ID: 17033432
    [Abstract] [Full Text] [Related]

  • 19. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
    Wong F, Raina N, Richardson R.
    Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
    [Abstract] [Full Text] [Related]

  • 20. Effect of transjugular intrahepatic portosystemic shunt placement on renal function: a 7-year, single-center experience.
    Anderson CL, Saad WE, Kalagher SD, Caldwell S, Sabri S, Turba UC, Matsumoto AH, Angle JF.
    J Vasc Interv Radiol; 2010 Sep; 21(9):1370-6. PubMed ID: 20691610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.